We investigated the mechanism of development and repair process of glomerular injury in a rat model of habu snake (Trimeresurus fl avoviridis) venom (HSV)-induced glomerulonephritis. Glomerulonephritis was induced in rats by intravenously injecting HSV at 3 mg/kg. Renal tissue was isolated and subjected to immunohistochemical analysis for expression levels of type IV collagen, heat shock protein 47 (HSP47), transforming growth factor-β (TGF-β), and matrix metalloproteinase-3 (MMP-3), as well as its transcription factor Ets-1. Expression levels of HSP47, TGF-β, and type IV collagen began to increase in the mesangial area starting from day 14 and peaked on day 21, followed by a gradual decrease. Expression levels of MMP-3 and Ets-1 started to increase coinciding with peak production of mesangial matrix on day 21, peaking on day 35, followed by gradual decrease. Expression of MMP-3 and Ets-1 persisted until day 63, whereas that of HSP47 and type IV collagen returned to baseline level at this time point. Time-course changes of extracellular matrix (ECM) accumulation in glomeruli in the HSV-induced glomerulonephritis model were correlated with those of factors involved in both ECM production and degradation systems. Continued expression of factors in the degradation system seems particularly important for the repair process. These fi ndings might lead to new therapies that prevent and repair glomerular injury.
Introduction
Mesangioproliferative glomerulonephritis is histologically characterized by proliferation of mesangial cells and accumulation of mesangial matrix. Glomerulonephritis-associated glomerular injury that progresses irreversibly often results in glomerular sclerosis and poor prognosis. Although it has been recognized that balance between extracellular matrix (ECM) production and degradation systems is an important determinant for changes in the ECM status in nephritic pathology, 1,2 the relationship between the two systems has not yet been elucidated in detail.
Heat shock protein 47 (HSP47) is a molecular chaperone indispensable for collagen production. 3 Upregulation of collagen coincides with glomerular sclerosis lesions in a range of disease settings including IgA nephropathy, 4 diabetic nephropathy, 5 anti-Thy1 nephropathy, 6 chronic kidney rejection, 7 radiation nephropathy, 8 multiple kidney cysts, 9 hypercholesterolemic kidney, 10 subtotal nephrectomy model, 11, 12 and obstructive nephropathy. 13, 14 Therefore, because upregulation of HSP47 coincides with collagen expression, HSP47 is thought to be strongly involved in the process of glomerular sclerosis.
Matrix metalloproteinases (MMPs), factors in the ECM degradation system, are a family of zinc-dependent proteinases that have the capacity to break down all components of the ECM. Currently, there are more than 20 known mammalian MMPs, which can be subdivided into collagenases (MMP-1, -8, -13, and -18), gelatinases (MMP-2 and -9), stromelysins (MMP-3, -10, and -11), matrilysins (MMP-7 and -26), membrane-type MMPs (MMP-14, -15, -16, -17, -24, and -25), and others (MMP-11, -12, -19, -20, -21, -23a, -23b, -27, and -28). 15 Among these, it was reported that MMP-3 is involved in degradation of type II and IV collagens and was demonstrated to be highly expressed at sites of collagen deposition. 16, 17 Ets-1 is well known as a transcription factor that directly regulates expression of MMPs. Indeed, Ets-1 has been reported to induce expression of MMP-3 in rat crescentic glomerulonephritis, 18 suggesting a close association between Ets-1 and MMP-3.
The habu snake venom (HSV)-induced reversible mesangioproliferative glomerulonephritis model is considered useful for elucidating the mechanism for production and degradation of ECM. Following intravenous injection of HSV, cystic ballooning-type lesions may be observed in glomeruli within 1 day. Subsequently, marked segmental proliferative lesions are observable in cystic areas; cellularity decreases, and reconstruction of the glomerular tuft gradually occurs over time. Eventually, the histological structure of the glomeruli returns almost to normal. 19 We used this reversible mesangioproliferative glomerulonephritis model to investigate time-course changes of expression of ECM production system factors such as HSP47 and type IV collagen as well as degradation system factors such as Ets-1 and MMP-3 immunohistochemically.
Methods

Animals
Male Sprague-Dawley rats weighing 200 g were housed in standard rodent cages, at constant ambient temperature (22° ± 1°C), and humidity (85%) with 10 h light/day, kept at the Biomedical Research Center of Center for Frontier Life Sciences at Nagasaki University. The animals had free access to laboratory chow and tap water.
Experimental design
Based on national regulations and guidelines, all experimental procedures were reviewed and approved (no. 0605220510) by the Institutional Animal Care and Use Committee of Nagasaki University.
Rats were intravenously injected with HSV (Wako Pure Chemical Industries, Osaka, Japan) dissolved in saline at a dose of 3 mg/kg body weight (HSV group, n = 36); control rats were injected with saline alone (S group, n = 4). Rats were killed before and on days 7, 14, 21, 28, 35, 49, and 63 after injections (n = 4 each), and renal tissues dissected out carefully. Tissues were fi xed with 4% paraformaldehyde (PFA) immediately after sampling for 24 h, embedded in paraffi n, and cut into 3-μm-thick sections for histological assessment to renal injury. Frozen tissues were also prepared by mounting in optimal cutting temperature compound (Miles, Elkhart, IN, USA) and rapidly freezing in dry ice, then stored at -80°C until use. Fresh frozen tissues were cut into 3-μm-thick sections using a microtome and placed onto aminopropyltriethoxysilane -coated glass slides.
Histological and immunohistochemical examination
To assess morphological changes in the kidney, paraffi nembedded tissue sections were stained with periodic acidSchiff (PAS) reaction. Then, morphological change was compared between the S group and the HSV group.
The following antibodies were used for immunohistochemical analysis: (1) rabbit anti-human type IV collagen antibody (10760; Progen Biotechnik, Heidelberg, Germany), diluted 1/100; (2) mouse anti-mouse HSP47 antibody (Stress-Gen, Victoria, BC, Canada), diluted 1/100; (3) rabbit anti-mouse TGF-β antibody (sc-146; Santa Cruz Biotechnology, Santa Cruz, CA, USA), diluted 1/50; (4) rabbit antirat MMP-3 antibody (sc-6839; Santa Cruz Biotechnology), diluted 1/100; (5) rabbit anti-human Ets-1 antibody (sc-350; Santa Cruz Biotechnology), diluted 1/100. Kidney sections were reacted with methanol containing 0.3% H 2 O 2 for 20 min at room temperature to block endogenous peroxidase. The peroxidase anti-peroxidase (PAP) technique was used to assess type IV collagen, MMP-3, and Ets-1 expression in paraffi n-embedded or frozen sections. After deparaffi nization, sections were incubated with blocking buffer containing 20% normal swine serum, 5% normal goat serum, 5% fetal calf serum, and 5% bovine serum albumin in phosphate-buffered saline for 30 min. For Ets-1 antibody, fresh frozen sections fi xed in 4% PFA at room temperature were reacted for 15 min, then incubated with blocking buffer as described above for 30 min. Sections were then reacted with the primary antibody and diluted in the same blocking buffer. After reacting with primary antibody at room temperature for 1 h, sections were reacted with horseradish peroxidase (HRP)-conjugated swine anti-rabbit immunoglobulin antibody (P0399; DAKO, Japan) diluted 1/50 at room temperature for 30 min and rabbit PAP (Z0113; DAKO) diluted 1/100 at room temperature for 30 min.
Indirect immunohistochemical analysis was used to detect HSP47 and TGF-β in paraffi n-embedded sections. After deparaffi nization, the sections were incubated with blocking buffer for 30 min as described above. Sections were then reacted with the primary antibody diluted in the same blocking buffer. After reacting with primary antibody at room temperature for 1 h, sections were reacted with HRP-conjugated goat anti-mouse antibody (Millipore, Billerica, MA, USA) diluted 1/100 for HSP47 or HRPconjugated goat anti-rabbit antibody (Millipore) diluted 1/100 for TGF-β at room temperature for 1 h.
For type IV collagen, HSP47, MMP-3, and Ets-1, positive reactions with antibodies were characterized by color development following reaction with H 2 O 2 and 3,3′-diaminobenzidine tetrahydrochloride (DAB). For TGF-β, HRP-positive sites were visualized using H 2 O 2 and DAB in the presence of nickel and cobalt ions. Finally, sections were counterstained with methyl green and mounted.
Negative control sections were reacted with normal mouse IgG in place of specifi c monoclonal antibodies or normal rabbit IgG in place of specifi c polyclonal antibodies.
Data processing and statistical analysis
For semiquantitative estimation of PAS-positive area and type IV collagen-, HSP47-, and MMP-3-positive areas in each glomerulus, we digitized images using image analysis software (Win Roof Mitanicorp, Chiba, Japan). Images were transformed into a matrix of 2,250 × 1,800 pixels and viewed at 400× magnifi cation. For each kidney sample, 20 cross sections of glomeruli were examined sequentially. The total number of glomerular cells, and numbers of TGF-β-and Ets-1-positive cells were also counted in 20 cross sections of glomeruli under 400× magnifi cation in each group.
Data are expressed as mean ± standard deviation (SD). Differences between groups were examined for statistical signifi cance by repeated-measures analysis of variance (ANOVA) (Bonferroni/Dunn test). P values < 0.001 denoted the presence of statistically signifi cant difference.
Results
Histological changes (PAS staining)
In the S group, mesangial cell proliferation and matrix increase were not observed throughout the observation period (data not shown), and the staining pattern remained the same as that of HSV group on day 0 (Fig. 1A) . On the other hand, in the HSV group mesangial cell proliferation and matrix increase were observed on day 21 following HSV injection, with a signifi cant difference from those seen on day 0 (Fig. 1B) . Mesangial cell proliferation and matrix increase were signifi cantly reduced on day 35 (Fig. 1C ) compared with on day 21, and the histological pattern on day 63 was almost the same as that on day 0 (Fig. 1D) . The time-course change of the mesangial matrix was semiquantitatively analyzed by the imaging system (Fig. 1E) .
Expression of type IV collagen Figure 2 shows immunohistochemical staining of type IV collagen. In the S group, slight deposition of type IV collagen in the mesangial area was observed throughout the observation period (data not shown), and the staining pattern remained the same as that of HSV group on day 0 ( Fig. 2A) . In contrast, in the HSV group, upregulation of type IV collagen was observed on day 21 following HSV injection, coinciding with the spread of mesangial area (Fig.  2B) . Upregulation of type IV collagen in mesangial area was signifi cantly reduced on day 35 (Fig. 2C ) compared with day 21, and the expression level on day 63 was the same as that on day 0 (Fig. 2D) . Positive area for type IV collagen as semiquantitatively analyzed by the imaging system over time is presented in Fig. 2E .
Expression of HSP47
In the S group, few or no HSP47-positive cells in the glomeruli were observed throughout the observation period, as in the HSV group on day 0 (Fig. 3A) . However, HSP47-positive cells were signifi cantly increased in the HSV group, starting on day 14 and peaking on day 21 following HSV injection, coinciding with the peak expression of type IV collagen (Fig. 3B) . The level of HSP47-positive cells decreased thereafter until day 63, when almost no positive cells were detected in the glomeruli (Fig. 3C,D) . The timecourse change of the HSP47-positive cell count in glomeruli is shown in Fig. 3E .
Expression of TGF-β TGF-β is widely known to be an important mediator in progressive fi brosis. Previous reports have demonstrated that TGF-β facilitated mesangial cell proliferation and stimulated ECM production by mesangial cells. 20 We therefore examined TGF-β expression. Few or no TGF-β-positive cells were observed in the glomeruli in the S group throughout the observation period or in the HSV group on day 0 (Fig. 4A) . However, TGF-β-positive cells increased significantly in the HSV group starting on day 14 and peaked from days 21-35 following HSV injection, coinciding with the peak expression levels of type IV collagen and HSP47 (Fig.  4B,C) . TGF-β-positive cells in glomeruli decreased thereafter until day 63 (Fig. 4D) . The time-course of changes in TGF-β-positive cell count in the glomeruli is shown in Fig. 4E .
Expression of MMP-3
In the S group, little or no expression of MMP-3 in glomeruli was observed throughout the observation period (data not shown), and the staining pattern was not different from that of HSV group on day 0 (Fig. 5A) . In contrast, in the HSV group, MMP-3 expression was increased on day 21 following HSV injection (Fig. 5B) , peaked on day 35 (Fig.  5C) , and remained signifi cantly upregulated thereafter (Fig. 5D) . Positive area for MMP-3 was semiquantitatively analyzed; the time-course change is presented in Fig. 5E .
Expression of Ets-1
In the HSV group, Ets-1-positive cells in the glomeruli were signifi cantly increased versus day 0 starting from day 21 (Fig. 6B) , peaking on day 35 following HSV injection (Fig.  6C) . Ets-1-positive cells decreased thereafter, but the level on day 63 was still signifi cantly higher than that on day 0 (Fig. 6A,D) . Time-course change of numbers of Ets-1-positive cells in a single glomerulus is shown in Fig. 6E .
Discussion
We investigated the time-course change of expression levels of collagen production system factors and collagen degrada- tion system factors in glomerular cells over the course of development and repair of glomerular injury using a rat model of HSV-induced glomerulonephritis. Our experiment suggests that histological changes in the glomeruli of HSVinduced glomerulonephritic rats were attributed to balancing of collagen production and degradation systems over time, as seen in the initial upregulation of production system factors followed by upregulation of degradation system factors.
It was previously reported that, in a rat model of HSVinduced glomerulonephritis, protease derived from intravenously injected HSV promotes mesangiolysis, resulting in mesangial proliferative lesions and subsequent spontaneous remission. 21, 22 In the present study, mesangiolysis was detected within 24 h of HSV injection, followed by peak increase of mesangial cells and matrix increases, which spontaneously decreased to baseline levels by day 63.
We fi rst investigated factors involved in the production of collagen, an ECM component, to elucidate the mechanism for the increase of ECM in the HSV-induced glomerulonephritis model. Expression levels of type IV collagen and HSP47, a molecular chaperone essential for collagen production, started to increase on day 7, peaked on day 21, and decreased thereafter. This fi nding suggests that the observed increase in ECM in the glomeruli in this rat model was attributable to accumulation of type IV collagen via upregulation of HSP47. That is, the extent of glomerular injury was correlated with expression levels of HSP47 and type IV collagen, indicating strong involvement of HSP47 expression in the increase of glomerular ECM. It has been reported that administration of antisense and siRNA against HSP47 reduced collagen accumulation and suppressed fi brosis of peritoneum and renal interstitium in a chlorhexidineinduced peritoneal fi brosis model and an unilateral ureteral ligation model. 23, 24 These and our fi ndings suggest that HSP47 could be a potential therapeutic target in the treatment of diseases that show irreversible increase in glomerular ECM. Moreover, previous reports have noted a crucial role for TGF-β in ECM production. TGF-β stimulated expression of types I, III, and IV collagen, laminin, fi bronectin, and heparin sulfate proteoglycans in various assays in cultured human mesangial cells or isolated perfused kidneys. 20 Based on these fi ndings, the time-course of TGF-β expression is consistent with that of HSP47 and type IV collagen.
We also investigated factors involved in degradation of collagen to elucidate the mechanism for decrease of ECM. Expression levels of MMP-3 and Ets-1 increased as mesangial matrix increased starting on day 7 after HSV injection, peaking on day 35, followed by gradual decrease thereafter but remaining upregulated versus baseline on day 63. These results suggest that increased expression of Ets-1 and MMP-3 may be involved in the repair mechanism in the HSV-induced glomerulonephritis model.
MMP-3 as well as MMP-10 and -11 are classifi ed together as stromelysins, important for the degradation of ECM components such as collagen type III, IV, and VI, laminin, aggrecan, and fi bronectin. 25, 26 Renal MMP-3 mRNA expression is decreased in rats with streptozotocin-induced diabetes. 27, 28 Similarly, in diabetic nephropathy and IgA nephropathy, expression of MMP-3 mRNA in the glomeruli correlated negatively with the degree of glomerular injury. 16, 17 These fi ndings suggest that reduced MMP-3 expression suppresses ECM degradation, resulting in progression of glomerular injury. In the present study, timedependent changes of expression of MMP-3, which followed HSP47 and type IV collagen expression induced by HSV injection, might lead to resolution of ECM in glomeruli.
Concerning regulation of MMP-3 genes, Ets-1 is known to be a potent transcription factor for MMP-3. Ets-1 comprises 450 amino acids and contains a DNA-binding ETS domain, transactivation domain, and Pointed domain. The ETS domain binds to the ETS-binding motif GGAA/T in the cis-acting element of target genes and cooperates with the c-Fos/c-Jun complex at the AP-1 site to activate expression of certain promoters. This motif has been found in the promoter region of numerous genes including MMP-1, MMP-3, MMP-9, u-PA, and tissue inhibitor of metalloproteinase (TIMP)-1. 29, 30 In addition, it was reported that Ets-1 blocked intracellular TGF-β signaling, resulting in suppression of ECM accumulation, and increased the levels of ECM degradation enzymes MMP-1, -3, and -9 in Thy-1 nephropathy. 31 Based on the background already described, induction of MMPs expression via transcriptional upregulation by Ets-1 is considered to be involved in remodeling of glomerular ECM. In our study, the time-course expression profi les of Ets-1 and MMP-3 are similar, and upregulation of MMP-3 via induction of Ets-1 is likely part of a mechanism that pushed the balance toward glomerular ECM degradation, leading to reversible changes in renal tissue.
There were some limitations to our study. First, the correlation between the morphological changes and proteinuria or renal function was not verifi ed. However, previous reports have clarifi ed an association between the levels of proteinuria and type IV collagen expression in mesangioproliferative glomerulonephritis models. 22, 32 Nakao et al. demonstrated a time-course for proteinuria in HSV-induced glomerulonephritis in mice. 32 They showed that proteinuria began to increase at day 3 following HSV injection, peaking at day 7 in parallel with a prominent proliferation of mesangial cells and an accumulation of ECM including type IV collagen. The level of proteinuria gradually decreased to baseline levels by day 42, and the expression level of type IV collagen followed the same course. Similarly, Masuda et al. revealed that the degree of proteinuria was closely correlated with the expression of type IV collagen in rat Thy-1/HSV-induced glomerulonephritis. 22 Based on these fi ndings, we anticipated that the level of proteinuria was associated with the expression of type IV collagen in our model, as we observed similar histopathological and immunohistochemical fi ndings over the course of mesangioproliferative glomerulonephritis. Second, although we performed Western blotting of proteins associated with ECM production and degradation to confi rm the results of immunohistochemical analysis, we were unable to produce any satisfactory results. However, the semiquantitative immunohistochemical method we used in the present study has been widely used and reported as a reliable technique in previous studies. 33, 34 Third, we were unable to clarify which cells in the glomeruli expressed the proteins associated with ECM production and degradation, and which cells in the glomeruli played an important role in the reversible process of HSV-induced glomerulonephritis. Based on their morphology of positive cells, we speculate that mesangial cells and podocytes are involved in this process, but further studies are needed to confi rm this hypothesis.
In conclusion, the time-course change of glomerular ECM accumulation during the course of HSV-induced glomerulonephritis was correlated with that of factors in both ECM production and degradation systems. Continued expression of factors in the ECM degradation system was considered particularly important for repair process. In future, to suppress nephritis progression from ECM accumulation to fi brosis in humans, it may be suggested that therapies that suppress factors in ECM production system and promote expression of factors in ECM degradation system could be useful for prevention and repair of glomerular injury.
